Dna Script Appoints Marc Montserrat As Chief Executive Officer and Thomas Ybert As Chief Scientific Officer

Oct 17, 2024•9 months ago

Position

Chief Scientific Officer

Company

DNA Script

Thomas Ybert

ParisBiotechnologyScience And Engineering

Description

DNA Script has announced the appointment of Marc Montserrat as its new Chief Executive Officer, while founding CEO Thomas Ybert, PhD, has transitioned to a new Chief Scientific Officer role, where he will continue to lead the company’s groundbreaking research and innovation efforts.

Company Information

Company

DNA Script

Location

Paris, Texas, United States

About

DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAX™️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months